205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.10%
Revenue growth at 50-75% of MPWR's 12.01%. Martin Whitman would worry about competitiveness or product relevance.
6.17%
Gross profit growth at 50-75% of MPWR's 12.04%. Martin Whitman would question if cost structure or brand is lagging.
15.50%
EBIT growth below 50% of MPWR's 31.64%. Michael Burry would suspect deeper competitive or cost structure issues.
15.25%
Operating income growth under 50% of MPWR's 31.64%. Michael Burry would be concerned about deeper cost or sales issues.
14.66%
Net income growth under 50% of MPWR's 41.80%. Michael Burry would suspect the firm is falling well behind a key competitor.
16.67%
EPS growth under 50% of MPWR's 40.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
16.92%
Diluted EPS growth under 50% of MPWR's 47.37%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-1.40%
Share reduction while MPWR is at 0.06%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.52%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.30%
Dividend reduction while MPWR stands at 0.29%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
71.83%
OCF growth under 50% of MPWR's 187.56%. Michael Burry might suspect questionable revenue recognition or rising costs.
82.73%
FCF growth under 50% of MPWR's 255.06%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
52.13%
10Y revenue/share CAGR under 50% of MPWR's 117.83%. Michael Burry would suspect a lasting competitive disadvantage.
6.46%
5Y revenue/share CAGR under 50% of MPWR's 26.58%. Michael Burry would suspect a significant competitive gap or product weakness.
12.10%
3Y revenue/share CAGR under 50% of MPWR's 43.26%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
48.23%
10Y OCF/share CAGR under 50% of MPWR's 96.98%. Michael Burry would worry about a persistent underperformance in cash creation.
24.14%
5Y OCF/share CAGR at 75-90% of MPWR's 30.02%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
29.91%
3Y OCF/share CAGR under 50% of MPWR's 1590.27%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
101.43%
Similar net income/share CAGR to MPWR's 99.44%. Walter Schloss would see parallel tailwinds or expansions for both firms.
7.87%
Positive 5Y CAGR while MPWR is negative. John Neff might view this as a strong mid-term relative advantage.
12.80%
Below 50% of MPWR's 67.93%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
33.75%
Below 50% of MPWR's 254.98%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
16.21%
5Y equity/share CAGR at 50-75% of MPWR's 27.74%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
-3.10%
Negative 3Y equity/share growth while MPWR is at 10.27%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
2216987.49%
Dividend/share CAGR of 2216987.49% while MPWR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
182.59%
Dividend/share CAGR of 182.59% while MPWR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
98.80%
3Y dividend/share CAGR of 98.80% while MPWR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
3.28%
AR growth is negative/stable vs. MPWR's 13.86%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-6.05%
Inventory is declining while MPWR stands at 3.61%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-5.66%
Negative asset growth while MPWR invests at 0.59%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.92%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-15.40%
We’re deleveraging while MPWR stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-1.25%
Our R&D shrinks while MPWR invests at 9.71%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-7.66%
We cut SG&A while MPWR invests at 4.22%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.